Response to tyrosine kinase inhibitors in chronic myeloid leukemia: experience from a west Asian developing country. [electronic resource]
Producer: 20150406Description: 274-80 p. digitalISSN:- 1865-3774
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- therapeutic use
- Benzamides -- therapeutic use
- Child
- Female
- Follow-Up Studies
- Humans
- Imatinib Mesylate
- Iraq
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Male
- Middle Aged
- Piperazines -- therapeutic use
- Protein Kinase Inhibitors -- therapeutic use
- Pyrimidines -- therapeutic use
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.